Class IIReported 2025-11-05

Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03

Recalled by ProRx LLC

Reason for Recall

Lack of Assurance of Sterility

Recall Number

D-0120-2026

Classification

Class II

Status

Ongoing